Entertainment

View All
Star Wars LEGO Day

West Chester’s Helicopter Museum Brings Star Wars and LEGO Fun Together for Family Day

WEST CHESTER, PA — “This is the way!” to spend a spring afternoon as the American Helicopter Museum and Education Center invites families to step into a galaxy of fun …

Lifestyle

View All
The Mill at Anselma

The Weight of the Wheel: The Living Legacy of Chester Springs

The wheel turns slowly, almost reluctantly, as water spills over the edge of the sluice and into Pickering Creek below. Inside the mill, the air carries a fine dusting of …

Pennsylvania

View All
The Pennsylvania Turnpike Lost Worker Memorial

Work Zone Deaths Persist as Officials Issue Safety Warning

HARRISBURG, PA — Nearly 1,400 crashes and 12 deaths in Pennsylvania work zones last year are prompting state officials to warn drivers to slow down as construction season ramps up.

National

View All
Department of Veterans Affairs

VA Hospitals Earn Full Accreditation, Showing Care Gains

WASHINGTON, D.C. — All 176 Veterans Affairs health care programs reviewed in 2025 met national quality and safety standards, according to a new assessment by the Joint Commission, signaling broad …

Latest Articles

View All

VA Hospitals Earn Full Accreditation, Showing Care Gains

WASHINGTON, D.C. — All 176 Veterans Affairs health care programs reviewed in 2025 met national quality and safety standards, according to a new assessment by the Joint Commission, signaling broad …

BrightView to Report Second-Quarter 2026 Results on May 5

BLUE BELL, PA — BrightView Holdings, Inc. (NYSE: BV) will release its second-quarter fiscal 2026 earnings results after market close on Tuesday, May 5, 2026, and will host a conference …

NRx Pharmaceuticals Responds to Executive Order on Mental Health Treatments

WILMINGTON, DE — NRx Pharmaceuticals (Nasdaq: NRXP) said it supports an executive order signed April 18, 2026, directing federal agencies to accelerate research and regulatory pathways for treatments targeting serious …

FDA Extends Review of Savara’s Molgramostim Application to November

LANGHORNE, PA — The U.S. Food and Drug Administration has extended the review period for Savara Inc.’s (Nasdaq: SVRA) biologics license application for molgramostim by three months, setting a new …

FDA Push to Cut Animal Testing Shows Early Progress

WASHINGTON, D.C. — Federal regulators say efforts to reduce animal testing in drug development are advancing, with the Food and Drug Administration reporting early progress on a plan aimed at …